Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLS | O94925 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.30 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23877361 | 0.89 | PTGDR2 (0.34) | SSTR4 | |
| SCHEMBL19984934 | 0.88 | TSHR (0.36) | GLSMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL23877356 | 0.80 | PIN1 (0.40) | ALDH1A1KDM4E | |
| SCHEMBL23877353 | 0.79 | ALDH1A1 (0.38) | ALDH1A1KDM4ERAB9AHTT | |
| SCHEMBL19985035 | 0.78 | MGAM (0.34) | MEN1KMT2ASSTR4ALDH1A1KDM4E | |
| SCHEMBL23877354 | 0.73 | ANO1 (0.36) | — | |
| SCHEMBL23877352 | 0.71 | NQO2 (0.35) | MEN1KMT2AALDH1A1KDM4ERAB9A | |
| SCHEMBL23877358 | 0.70 | NFE2L2 (0.37) | SSTR4 | |
| SCHEMBL19984925 | 0.70 | PIN1 (0.41) | ALDH1A1 | |
| SCHEMBL21538699 | 0.69 | L3MBTL1 (0.36) | GLSMEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | FGF1, MST1, CDC20 | GLS 2333/4885HTR2B 3588/4885MEN1 3340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.